申请人:RHONE POULENC RORER LIMITED
公开号:EP0506437A1
公开(公告)日:1992-09-30
Imidazole derivatives of the formula:
wherein R¹ represents optionally substituted phenyl, R² represents alkyl optionally substituted by hydroxy, X¹ represents a bond, oxygen, -S(0)n-, -CH₂0- or - CH₂N(R⁶)-, wherein n is 0, 1 or 2 and R⁶ represents hydrogen, alkyl, acyl alkylsulphonyl or, -C(X³)NR⁷R⁸, wherein X³ represents oxygen or sulphur and R⁷ and R⁸ represent hydrogen, alkyl, or optionally substituted phenyl, m is zero or 1 to 8, X² represents a bond, oxygen, -S(0)p- wherein p is 0, 1 or 2, or a group -C(0)NR⁴-, -C(S)NR⁴-, -OC(0)NR⁴-, -OC(S)NR⁴-, -NR⁴C(0)- or -NR⁴C(S)-, wherein R⁴ represents hydrogen or alkyl and R³ represents optionally substituted heterocyclyl, or cycloalkyl or, except when X¹ and X² are direct bonds, R³ represents optionally substituted phenyl, or R³ represents amino, alkylamino, benzylamino, benzyl(alkyl)amino, dialkylamino, aminoalkyl, alkylaminoalkyl, benzylaminoalkyl, benzyl(alkyl)aminoalkyl or dialkylaminoalkyl, or a cyclic imino group, and salts thereof possess useful pharmacological properties.
Imidazole衍生物的化学式如下:
其中R¹代表可选择取代的苯基,R²代表可选择取代的烷基,其上带有羟基,X¹代表键,氧,-S(0)n-,-CH₂0-或- CH₂N(R⁶)-,其中n为0,1或2,R⁶代表氢,烷基,酰基烷基磺酰基或,-C(X³)NR⁷R⁸,其中X³代表氧或硫,R⁷和R⁸代表氢,烷基,或可选择取代的苯基,m为零或1至8,X²代表键,氧,-S(0)p-,其中p为0,1或2,或一个基团-C(0)NR⁴-,-C(S)NR⁴-,-OC(0)NR⁴-,-OC(S)NR⁴-,-NR⁴C(0)-或-NR⁴C(S)-,其中R⁴代表氢或烷基,R³代表可选择取代的杂环烷基,或环烷基或,除非X¹和X²是直接键,R³代表可选择取代的苯基,或R³代表氨基,烷基氨基,苄基氨基,苄(烷基)氨基,二烷基氨基,氨基烷基,烷基氨基烷基,苄基氨基烷基,苄(烷基)氨基烷基或二烷基氨基烷基,或一个环状亚胺基团,及其盐具有有用的药理学性质。